A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.
about
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancerHerpes simplex virus: an occupational hazard in dentistryOral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving infliximab: a case report.Herpetic Keratouveitis and Trabeculectomy Failure during Infliximab Therapy in a Patient with Behçet's Disease
P2860
A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@ast
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@en
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@nl
type
label
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@ast
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@en
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@nl
prefLabel
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@ast
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@en
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@nl
P2093
P1433
P1476
A risk-benefit evaluation of a ...... rpes simplex virus infections.
@en
P2093
C V Fletcher
P L Anderson
P304
P356
10.2165/00002018-200023020-00004
P577
2000-08-01T00:00:00Z
P6179
1048124806